Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey

Journal of Medical Virology

Volumn 78, Issue 4, 2006, Pages 466-472

  Davaalkham, Dambadarjaa ^a,b   Ojima, Toshiyuki ^a   Nymadawa, Pagvajav ^c   Uehara, Ritei ^a   Watanabe, Makoto ^a   Oki, Izumi ^a   Nakamura, Yosikazu ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Health Sciences University   (Mongolia)

^c National Center for Communicable Diseases   (Mongolia)

Author keywords

Children; Epidemiology; HCV; Iatrogenic transmission; Mongolia

Indexed keywords

HEPATITIS C ANTIBODY;

DENTAL CARE; DISINFECTION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNORADIOMETRIC ASSAY; INFECTION CONTROL; INSTRUMENT STERILIZATION; MALE; MONGOLIA; NORMAL HUMAN; REVIEW; RISK FACTOR; SCHOOL CHILD; SURGERY; VIRUS TRANSMISSION;

CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IATROGENIC DISEASE; LOGISTIC MODELS; MALE; MONGOLIA; MULTIVARIATE ANALYSIS; PREVALENCE; RISK FACTORS;

HEPATITIS C VIRUS;

EID: 33644758582     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20563     Document Type: Review

References (42)

1. Ackerman Z, Ackerman E, Paltiel O. 2000. Intrafamilial transmission of hepatitis C virus: A systematic review. J Vir Hepat 7:93-103.
2. Allander T, Gruber A, Naghavi M, Beyene A, Soderstrom T, Bjorkholm M, Grillner L, Persson MAA. 1995. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345:603-607.
3. Alter MJ. 2002. Prevention of spread of hepatitis C. Hepatology 36:S93-S98.
4. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. 1999. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Eng J Med 341:556-562.
5. Amarapurkar D. 2000. Natural history of hepatitis C virus infection. J Gastroenterol Hepatol 15:E105-E110.
6. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G. 2005. Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76:327-332.
7. Baatarkhuu O, Dagvadorj Ya, Zulkhuu G, Khorolsuren H. 2004. Prevalence of HCV infection among Mongolian population. The 10th National Conference on "Current Topics of Virology". Ulaanbaatar, Abstract, p 41-42.
8. Blood Center of Mongolia. 2003. Statistical indicators of blood center of Mongolia. Dedicated to 40th anniversary of Blood Center of Mongolia, Ulaanbaatar, Mongolia.
9. Chlabicz S, Grzeszczuk A, Prokopowicz D. 2004. Medical procedures and the risk factors from hepatitis C infection: Case-controlled study in north-eastern Poland. J Hosp Infect 58:204-208.
10. Dagwadorj Y, Davaasuren D, Gantuya S. 1999. Chronic HBV, HDV and HCV infection in Mongolian children. Liver cirrhosis and its development. Switzerland, Basel, p 78.
11. Davaalkham J, Damdindorj B, Uurtuya Sh, Khurelbaatar N. 2004. The study on hepatitis B and C virus markers among patients with liver cancer. The 10th National Conference on "Current Topics of Virology". Ulaanbaatar, Abstract, p 132-133.
12. Ebright JR, Altantsetseg T, Oyungerel R. 2003. Emerging infectious diseases in Mongolia. Emerg Infect Dis 9:1509-1515.
13. Ferreiro MC, Dios PD, Scully C. 2005. Transmission of hepatitis C virus by saliva? Oral Disease 11:230-235.
14. Feucht HH, Zöllner B, Schröter M, Altrogge H, Laufs R. 1995. Tear fluid of Hepatitis C virus carriers could be infectious. J Clin Microbiol 33:2202-2203.
15. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, Khoby TE, Abdel-Wahab Y, Ohn ESA, Anwar W, Sallam I. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
16. Fujioka S, Shimomura H, Ishii Y, Kondo J, Fujio K, Ikeda F, Miyake M, Kusachi S, Tsuji T. 1998. Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals. Kansenshogaku Zasshi 72:5-11.
17. Gaeta GB, Stroffolini T, Taliani G, Ippolito FM, Giusti G, Bac CD. 1999. Surgical procedures as a major risk factor for chronic hepatitis C virus infection in Italy: Evidence from a case-control study. Int J Infect Dis 3:207-210.
18. Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, Butler K. 2000. Mother-to-child transmission of hepatitis C virus: Evidence for preventable peripartum transmission. Lancet 356:904-907.
19. Habib M, Mohamed MK, Abdel-Aziz F, Magder LS, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Anwar W, Strickland GT, Fix AD, Sallam I. 2001. Hepatitis C virus infection in a community of Nile Delta: risk factors for seropositivity. Hepatology 33:248-253.
20. Heintges T, Wands JR. 1997. Hepatitis C virus: Epidemiology and transmission. Hepatology 26:521-526.
21. Ho MS, Yang CS, Chen PJ, Mau YC. 1994. Intrafamilial transmission of hepatitis C virus. J Clin Microbiol 32:2824-2826.
22. Kao JH, Chen DS. 2000. Transmission of hepatitis C virus in Asia: past and present perspectives. Towards control of hepatitis C in the Asia-Pacific region. J Hepatol Gastroenterol 15:E91-E96.
23. Kondo Y, Mizokami M, Nakano T, Kato T, Ueda R, Mukaide M, Hikiji K, Ishida T, Dorjsuren D, Dashnyam B, Oyunsuren T. 1997. Prevalence and molecular epidemiology of GB virus C/hepatitis G virus infection in Mongolia. J Med Virol 52:143-148.
24. Lvov DK, Samokhvalov EI, Tsuda F, Selivanov NA, Okamoto H, Stakhanova VM, Stakhgildyan IV, Doroshenko NV, Yashina TL, Kuzin SN, Suetina IA, Deryabin PG, Ruzaeva LA, Bezgodov VN, Firsova LA, Sorinson SN, Mishiro S. 1996. Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia. Arch Virol 141:1613-1622.
25. Major ME, Rehermann B, Feinstone SM. 2001. Hepatitis C viruses. In: Knipe DM, Howley PM, editors. Fields Virology. Volume 1, 4th edition. Philadelphia: Lippincott Williams & Wilkins. p 1004-1041.
26. Mele A, Sagliocca L, Manzillo G, Converti F, Amoroso P, Stazi MA, Ferrigno L, Rapicetta M, Franco E, Adamo B, Palumbo F, Sbreglia C, Pana A, Pasquini P, the SEIEVA Collaborating Group. 1994. Risk factors for acute non-A, non-B hepatitis and their relationship to antibodies for hepatitis C virus: A case-control study. Am J Public Health 84:1640-1643.
27. Ministry of Education, Technology, Sciences, and Culture of Mongolia. 2003. A statistical report. Ulaanbaatar, Mongolia.
28. Ministry of Health, The directorate of Medical Services, Mongolia. 2002. Health sector-80 years, Ulaanbaatar, Mongolia.
29. Ministry of Health, The directorate of Medical Services, Mongolia. 2004. Annual Health Report-2004, Ulaanbaatar, Mongolia (available at http://www.moh.mn/).
30. Nakashima K, Ikematsu H, Hayashi J, Kishihara Y, Mitsutake A, Kashiwagi S. 1995. Intrafamilial transmission of hepatitis C virus among the population of an endemic area of Japan. JAMA 274:1459-1461.
31. National Statistical Office of Mongolia, United Nations Population Fund, United Nations Statistics Division. 2001. Population and housing census: The main results. Ulaanbaatar, Mongolia.
32. Nerriniet E, Pouillot R, Lachenal G, Njouom R, Mfoupouendoun J, Bilong C, Mauclere Ph, Pasquier Ch, Ayouba A. 2005. Hepatitis C virus infection in Cameroon: A cohort-effect. J Med Virol 76:208-214.
33. Okamoto M, Nagata I, Murakami J, Kaji Sh, Iitsuka T, Hoshika T, Matsuda R, Tazawa Y, Shiraki K, Hino S. 2000. Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: High viral load, vaginal delivery, and negative anti-NS4 antibody. J Infect Dis 182:1511-1514.
34. Oyunbileg J, Kupul J, Tsatsral Kh. 1992. Prevalence of HBV, HCV and HDV infection in Mongolian population. The 8th National Conference on "Current Topics of Virology." Ulaanbaatar, Abstract, pp. 11-16.
35. Oyunsuren Ts, Togos S, Odgerel Z. 1996. Prevalence of HBV and HCV infections in population of Ulaanbaatar. Mongolian Med Sci 4:17-20.
36. Ramadori G, Meier V. 2001. Hepatitis C virus infection: 10 years after the discovery of the virus. Eur J Gastroenterol Hepatol 13:465-471.
37. Report of a WHO Consultation Organization in Collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. 1999. Global surveillance and control of hepatitis C. J Viral Hepatitis 6:35-47.
38. Roberts EA, Yeung L. 2002. Maternal-infant transmission of hepatitis C virus infection. Hepatology 36:8106-8113.
39. Sun CA, Chen HC, Lu CF, You SL, Mau YC, Ho MS, Lin SH, Chen CJ. 1999. Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey. J Med Virol 59:290-296.
40. Takahashi M, Nishizawa T, Gotanda Y, Tsuda F, Komatsu F, Kawabata T, Hasegawa K, Altankhuu M, Ulziiburen Ch, Narantuya L, Hoshino H, Hino K, Kagawa Y, Okamoto H. 2004. High prevalence of antibodies to Hepatitis A and E viruses and viremia of Hepatitis B, C and D viruses among Apparently healthy populations in Mongolia. Clin Diag Lab Immunol 11:392-398.
41. Wasley A, Alter MJ: 2000. Epidemiology of hepatitis C: Geographic differences and temporal trends. Semin Liv Diseas 20:1-16.
42. Yoshizawa H. 2002. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: Projection to other countries in the foreseeable future. Oncology 62:S8-S17.